4//SEC Filing
Kovach John S 4
Accession 0001493152-20-022851
CIK 0001335105other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 8:41 PM ET
Size
7.3 KB
Accession
0001493152-20-022851
Insider Transaction Report
Form 4
Kovach John S
DirectorPresident10% Owner
Transactions
- Purchase
Common Stock
2020-11-30$4.75/sh+21,100$100,225→ 1,540,183 total(indirect: By Trust) - Purchase
Warrants to Purchase Common Stock
2020-11-30$4.75/sh+21,100$100,225→ 21,100 total(indirect: By Trust)Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (21,100 underlying)
Footnotes (1)
- [F1]The reporting person acquired 21,100 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001368556
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 8:41 PM ET
- Size
- 7.3 KB